Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas.

about

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas.

Item

http://www.wikidata.org/entity/Q37728846

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacodynamic and pharmacoki ...... h peripheral T-cell lymphomas.

@en

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination

@nl

type

Item

label

Pharmacodynamic and pharmacoki ...... h peripheral T-cell lymphomas.

@en

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination

@nl

prefLabel

Pharmacodynamic and pharmacoki ...... h peripheral T-cell lymphomas.

@en

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination

@nl

P1476

Pharmacodynamic and pharmacoki ...... h peripheral T-cell lymphomas.

@en

P2093

Feng-qin Wu

http://www.w3.org/2001/XMLSchema#string

Hai-feng Yu

http://www.w3.org/2001/XMLSchema#string

Luo Fang

http://www.w3.org/2001/XMLSchema#string

Lü-hong Luo

http://www.w3.org/2001/XMLSchema#string

Neng-ming Lin

http://www.w3.org/2001/XMLSchema#string

Yun Fan

http://www.w3.org/2001/XMLSchema#string

Zhi-yu Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Clinical uses of pegylated pharmaceuticals in oncology.

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug.

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.

P2888

aps.2010.217

P304

408-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2010.217

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50271547

http://www.w3.org/2001/XMLSchema#string

P698

21372831

http://www.w3.org/2001/XMLSchema#string

P932

4002772

http://www.w3.org/2001/XMLSchema#string